Vaxart
VXRT
$0.70
Share price
-6.54%
Change (1 day)
-15.66%
Change (1 year)
Categories
P/S ratio for Vaxart (VXRT)
P/S ratio as of May 2024 (TTM): 14.3
According to Vaxart's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 14.3039. At the end of 2023 the company had a P/S ratio of 9.57.
P/S ratio history for Vaxart from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 9.57 | -99.19% |
| 2022 | > 1000 | 33.62% |
| 2021 | 882 | 470.99% |
| 2020 | 154 | 8908.16% |
| 2019 | 1.72 | -46.87% |
| 2018 | 3.23 | 15.04% |
| 2017 | 2.81 | -42.73% |
| 2016 | 4.90 | -12.41% |
| 2015 | 5.59 | 273.5% |
| 2014 | 1.50 | -33.78% |
| 2013 | 2.26 | -75.45% |
| 2012 | 9.21 | 69.53% |
| 2011 | 5.43 | -22.72% |
| 2010 | 7.03 | -69.81% |
| 2009 | 23.3 | |
| 2007 | 2.61 | -42.95% |
| 2006 | 4.58 | 126.8% |
| 2005 | 2.02 | -57.75% |
| 2004 | 4.78 | 16.6% |
| 2003 | 4.10 | 235.86% |
| 2002 | 1.22 | -27.46% |
| 2001 | 1.68 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |
 NRC Health
NRC | 5.62 | -60.72% | 🇺🇸 USA |